Status:
COMPLETED
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
Lead Sponsor:
Wandercraft
Conditions:
Spinal Cord Injury
Tetraplegia/Tetraparesis
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this clinical trial is to determine whether the Atalante X exoskeleton can be safely utilized by patients with tetraplegia and high paraplegia (at or above T4).
Eligibility Criteria
Inclusion
- ≥18 years old,
- Tetraplegia or high paraplegia (at or above T4) regardless of the cause,
- Non-opposition to the participation to the study,
- Having undergone a minimum of 1 session with the Atalante device from February 2019, to now.
Exclusion
- Neurological Level of Injury below T4 as determined by the International Standards for Neurological Classification of SCI
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06939634
Start Date
June 1 2024
End Date
September 1 2024
Last Update
April 23 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Hopale
Berck, France, France, 62600
2
CMPR de Pionsat
Pionsat, France, France, 63330
3
Hôpital La Musse
Saint-Sébastien-de-Morsent, France, France, 27180